When to Administer D5W (5% Dextrose in Water)
D5W should be administered primarily to prevent hypoglycemia in young children requiring IV maintenance fluids (combined with isotonic saline as D5 in 0.9% saline), to treat hypernatremia in critically ill patients, and to prevent overcorrection of severe hyponatremia during continuous renal replacement therapy.
Primary Indications
Prevention of Hypoglycemia in Pediatric Maintenance Fluids
Young children (especially infants around 1 year old) require adequate glucose provision—typically 5% dextrose—in their maintenance IV solutions to prevent hypoglycemia, which occurs more commonly in this age group. 1
The dextrose must be combined with isotonic saline (0.9% saline + 5% dextrose or balanced isotonic solution with dextrose), NOT administered as D5W alone, because hypotonic fluids like D5W are contraindicated as standard maintenance fluids in acutely ill children. 1
The American Academy of Pediatrics (2018) provides Grade A evidence that isotonic solutions should be the default maintenance fluid for all children aged 28 days to 18 years, with dextrose added to prevent hypoglycemia. 1
Treatment of Hypernatremia in ICU Patients
Parenteral D5W is effective for treating ICU-acquired hypernatremia, producing an estimated mean decrease of 2.25 mEq/L per liter of D5W administered. 2
D5W was slightly more effective than enteral free water at lowering serum sodium levels in patients with ICU-acquired hypernatremia, though both modalities are appropriate treatment options. 2
Typical treatment volumes range from 799 mL daily (median), with treatment duration averaging 6 days for hypernatremia correction. 2
Prevention of Overcorrection During Continuous Renal Replacement Therapy (CRRT)
When patients with severe hyponatremia require CRRT, calculated amounts of D5W can be infused prefilter (pre-blood pump) to prevent dangerous overcorrection of sodium levels that would otherwise occur from isotonic replacement fluids. 3
This strategy prevents osmotic demyelination syndrome while still allowing delivery of recommended effluent volumes of 20-25 mL/kg/hr. 3
The D5W rate is calculated based on the prescribed effluent volume to maintain sodium correction rates below 8 mEq/day. 3
Important Contraindications and Caveats
NOT for Standard Adult Maintenance Fluids
D5W should not be used as a drug diluent or standard maintenance fluid in critically ill adults, as changing from D5W to saline diluents increases hypernatremia and hyperchloremia risk without affecting mortality or other major outcomes. 4
However, balanced crystalloid solutions are generally preferred over chloride-rich solutions (0.9% NaCl) for large-volume resuscitation in hemorrhagic shock, though this recommendation applies to crystalloid choice rather than dextrose-containing solutions. 5
Pediatric Safety Concerns
Hypotonic fluids including D5W substantially raise the risk of life-threatening hyponatremia in acutely ill children and are contraindicated as standard maintenance fluids. 1
Hyponatremia occurs in 15-30% of hospitalized children receiving hypotonic fluids, with risk of hyponatremic encephalopathy that can be fatal or cause irreversible brain injury. 1
Studies comparing 0.45% saline in 5% dextrose versus 0.9% saline in 5% dextrose showed significantly more hyponatremia at 12 and 24 hours with the hypotonic solution. 6
Obstetric Contraindication
Large amounts of dextrose infusions (>25g) immediately before cesarean delivery cause fetal hyperglycemia, hyperinsulinemia, neonatal hypoglycemia, metabolic acidosis, and increased neonatal jaundice. 7
Dextrose infusions before delivery should be limited to no more than 6 g/hour to avoid fetal and neonatal harm. 7
Monitoring Requirements When Using D5W
Blood glucose must be checked at least daily (more frequently if symptomatic) to avoid hypoglycemia or hyperglycemia from dextrose administration. 1
Serum sodium should be measured immediately when treating hypernatremia and monitored regularly to track correction rates. 1, 2
When preventing overcorrection during CRRT, ensure sodium correction does not exceed 8 mEq/day to avoid osmotic demyelination syndrome. 3
Calculate total fluid intake comprehensively, including all IV fluids, medication infusions, line flushes, and enteral feeds when dextrose solutions are part of the regimen. 1